Early research (Phase 1)Ended earlyNCT04162301What this trial is testingCS3002 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor CStone Pharmaceuticals 10
Testing effectiveness (Phase 2)Looking for participantsNCT05867251What this trial is testingStudy of AVZO-021 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorHR+/HER2- Breast CancerHR+, HER2-, Advanced Breast Cancer+6 more Avenzo Therapeutics, Inc. 430
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07307053What this trial is testingRare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Who this might be right forRare Malignant NeoplasmAdvanced Solid TumorsMetastatic Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 600
Testing effectiveness (Phase 2)Looking for participantsNCT07030257What this trial is testingStudy of CP-383 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more Tasca Therapeutics 150
Early research (Phase 1)Ended earlyNCT00585845What this trial is testingStudy of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentWho this might be right forMalignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more Anza Therapeutics, Inc. 17
Not applicableLooking for participantsNCT04945330What this trial is testingNTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the GenesWho this might be right forAdvanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion Bayer 100
Not applicableLooking for participantsNCT04515810What this trial is testingMobile Health Application (PACT) to Improve Engagement in Advance Care PlanningWho this might be right forLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Hematologic Malignancy+1 more Fred Hutchinson Cancer Center 400
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Looking for participantsNCT05859074What this trial is testingMQ710 With and Without Pembrolizumab in People With Solid Tumor CancerWho this might be right forCutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Testing effectiveness (Phase 2)Active Not RecruitingNCT03839342What this trial is testingBinimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF MutationsWho this might be right forSolid Tumor University Health Network, Toronto 26
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Early research (Phase 1)Ended earlyNCT03976050What this trial is testingPhase I Study of HL-085 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Shanghai Kechow Pharma, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Early research (Phase 1)Not Yet RecruitingNCT07615413What this trial is testingPhase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.Who this might be right forKRAS G12C Mutation Advanced Solid Tumor Jiangsu Hansoh Pharmaceutical Co., Ltd. 636
Testing effectiveness (Phase 2)Looking for participantsNCT06818643What this trial is testingEvaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Who this might be right forAdvanced Solid TumorsMalignant Neoplasm Merck Sharp & Dohme LLC 270
Testing effectiveness (Phase 2)Looking for participantsNCT07466160What this trial is testingA Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid TumorsWho this might be right forSolid Tumor Mabwell (Shanghai) Bioscience Co., Ltd. 280
Early research (Phase 1)Ended earlyNCT00195325What this trial is testingStudy Evaluating TTI-237 in Advanced Malignant Solid Tumors.Who this might be right forTumorsNeoplasms Wyeth is now a wholly owned subsidiary of Pfizer 45
Testing effectiveness (Phase 2)Ended earlyNCT04259450What this trial is testingStudy to Assess AFM24 in Advanced Solid CancersWho this might be right forAdvanced Solid Tumor Affimed GmbH 85
Early research (Phase 1)Study completedNCT03941262What this trial is testingSafety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional TherapyWho this might be right forRefractory CancerMetastatic CancerRecurrent Cancer+4 more NKGen Biotech, Inc. 27